SGN-LIV1A: a development stage antibody drug-conjugate targeting LIV-1 for the treatment of metastatic breast cancer.

被引：3
|
作者：
Sussman, Django [1 ]
Smith, Leia M. [1 ]
Anderson, Martha E. [1 ]
Duniho, Steve [1 ]
Hunter, Joshua H. [1 ]
Kostner, Heather [1 ]
Miyamoto, Jamie B. [1 ]
Nesterova, Albina [1 ]
Westendorf, Lori [1 ]
Van Epps, Heather A. [1 ]
Whiting, Nancy [1 ]
Benjamin, Dennis R. [1 ]
机构：
[1] Seattle Genet, Bothell, WA USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-3962
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3962
引用
收藏
页数：1
相关论文
共 50 条
  • [1] SGN-LIV1A: A Novel Antibody-Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer
    Sussman, Django
    Smith, Leia M.
    Anderson, Martha E.
    Duniho, Steve
    Hunter, Joshua H.
    Kostner, Heather
    Miyamoto, Jamie B.
    Nesterova, Albina
    Westendorf, Lori
    Van Epps, Heather A.
    Whiting, Nancy
    Benjamin, Dennis R.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (12) : 2991 - 3000
  • [2] SGN-LIV1A, an antibody-drug conjugate (ADC), in patients with LIV-1-positive breast cancer.
    Kostic, Ana
    Anderson, Martha
    Duniho, Steven
    Miyamoto, Jamie
    Nesterova, Albina
    Sussman, Django
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Interim analysis of a phase 1 study of the antibody-drug conjugate SGN-LIV1A in patients with metastatic breast cancer
    Forero, A.
    Burris, H., III
    Mita, M.
    Specht, J.
    Weise, A.
    Liu, M. C.
    Modi, S.
    Pusztai, L.
    Kostic, A.
    Yang, J.
    Li, M.
    Hengel, S.
    Miller, K.
    CANCER RESEARCH, 2016, 76
  • [4] SGN-LIV1A: A phase 1 trial evaluating a novel antibody-drug conjugate in patients with LIV-1-positive breast cancer
    Forero, Andres
    Burris, Howard, III
    LoRusso, Patricia
    Specht, Jennifer
    Miller, Kathy
    Mita, Monica
    Liu, Minetta C.
    Modi, Shanu
    Pusztai, Lajos
    Sussman, Django
    Kostic, Ana
    CANCER RESEARCH, 2015, 75
  • [5] Phase 1 study of the antibody-drug conjugate (ADC) SGN-LIV1A in patients with heavily pretreated metastatic breast cancer
    Forero-Torres, A.
    Modi, S.
    Specht, J.
    Miller, K.
    Weise, A.
    Burris, H., III
    Liu, M.
    Krop, I.
    Pusztai, L.
    Kostic, A.
    Li, M.
    Mita, M.
    CANCER RESEARCH, 2017, 77
  • [6] Anti-human LIV-1 antibody drug conjugate for treatment of metastatic prostate cancer
    Zhao, Xiaobei
    Chen, Gang
    CANCER RESEARCH, 2023, 83 (11)
  • [7] Phase 1 study of the antibody-drug conjugate SGN-LIV1A in patients with heavily pretreated triple-negative metastatic breast cancer
    Modi, Shanu
    Pusztai, Lajos
    Forero, Andres
    Mita, Monica
    Miller, Kathy D.
    Weise, Amy
    Krop, Ian
    Burris, Howard, III
    Kalinsky, Kevin
    Tsai, Michaela
    Liu, Minetta C.
    Hurvitz, Sara A.
    Wilks, Sharon
    Ademuyiwa, Foluso
    Diab, Sami
    Han, Hyo S.
    Kato, Giraldo
    Nanda, Rita
    O'Shaughnessy, Joyce
    Kostic, Ana
    Li, Martha
    Specht, Jennifer
    CANCER RESEARCH, 2018, 78 (04)
  • [8] LIV-1 Antibody-Drug Conjugate: A Novel Therapeutic Agent for Breast Cancer
    Smith, L. M.
    Sussman, D.
    Nesterova, A.
    Westendorf, L.
    Duniho, S.
    Anderson, M.
    Mbow, B.
    Gregoire, A.
    Hunter, J.
    Whiting, N.
    Law, C. L.
    Benjamin, D. R.
    CANCER RESEARCH, 2010, 70
  • [9] Preclinical combinations of the antibody-drug conjugate SGN-LIV1A with chemotherapies show increased activity
    Li, Fu
    Anderson, Martha
    Hunter, Joshua
    Miyamoto, Jaime
    Ulrich, Michelle
    Kostic, Ana
    Law, Che-Leung
    Sussman, Django
    CANCER RESEARCH, 2016, 76
  • [10] LIV-1 antibody-drug conjugate: A novel therapeutic agent for breast and prostate cancer
    Sussman, Django
    Nesterova, Albina
    Westendorf, Lori
    Duniho, Steven
    Anderson, Martha
    Mbow, Brianna
    Gregoire, Ashley
    Hunter, Joshua H.
    Whiting, Nancy
    Corey, Eva
    Vessella, Robert L.
    Benjamin, Dennis R.
    Smith, Leia M.
    CANCER RESEARCH, 2011, 71
12345